摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Dihydroprotopine | 64191-02-2

中文名称
——
中文别名
——
英文名称
Dihydroprotopine
英文别名
4,6,7,14-tetrahydro-13-hydroxy-5-methyl-bis<1,3>benzodioxolo<4,5-c:5',6'-g>(5H)azecin;5-methyl-4,5,6,7,13,14-hexahydro-[1,3]dioxolo[4',5':5,6]benzo[1,2-c][1,3]dioxolo[4',5':4,5]benzo[1,2-g]azecin-13-ol;5-methyl-4,5,6,7,13,14-hexahydro-[1,3]dioxolo[4',5':5,6]benzo[1,2-c][1,3]dioxolo[4',5':4,5]benz[1,2-g]azecin-13-ol;Dihydroprotopin;Bihydroprotopine;15-methyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-ol
Dihydroprotopine化学式
CAS
64191-02-2
化学式
C20H21NO5
mdl
——
分子量
355.39
InChiKey
VVKPTQWGSHLYGL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    26
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    60.4
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Dihydroprotopine三氟乙酸 作用下, 以 氯仿 为溶剂, 反应 0.5h, 生成 N‐methylstylopine
    参考文献:
    名称:
    从protopines轻松合成四氢protoberberine和protoberberine生物碱并研究其抗菌活性。
    摘要:
    以protopines为起始原料,容易合成包括四氢小pro碱,N-甲基四氢小ber碱和小ine碱在内的一系列异喹啉生物碱。评价了所有化合物对四种病原菌大肠杆菌,金黄色葡萄球菌,鸡葡萄球菌和霍乱沙门氏菌的抗菌活性。实验结果表明,原小ber碱是被测生物碱中对靶细菌活性最高的化合物。有人提出,具有较高芳香化水平的平面分子(例如黄连5和小ber碱6))或分子的正电荷(例如N-甲基四氢小pro碱11和12)对抗菌作用具有积极影响。
    DOI:
    10.1080/14786419.2013.867344
  • 作为产物:
    描述:
    leptocarpine 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以44%的产率得到Dihydroprotopine
    参考文献:
    名称:
    Taborska, Eva; Bochorakova, Hana; Sedmera, Petr, Heterocycles, 1995, vol. 41, # 4, p. 799 - 806
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • On the Synthesis of Protopine Alkaloids
    作者:Yasuhiro Wada、Harumi Kaga、Shiho Uchiito、Eri Kumazawa、Miho Tomiki、Yu Onozaki、Nobuhito Kurono、Masao Tokuda、Takeshi Ohkuma、Kazuhiko Orito
    DOI:10.1021/jo071038y
    日期:2007.9.1
    For the synthesis of protopine alkaloids, we studied a reaction sequence based on a ring enlargement of indeno[2,1-a][3]benzazepines by a singlet oxygen oxygenation, followed by conversion of an amide carbonyl group of the resultant 10-membered keto-lactam to a methylene group, which is the last step for completion of the synthesis. The key substances, indeno[2,1-a][3]benzazepines, were prepared by
    为了合成原松碱生物碱,我们研究了基于单重氧合氧化茚并[2,1- a ] [3]苯并ze庚因的环扩大,然后转化所得的10元酰胺基的反应顺序。酮内酰胺成亚甲基,这是完成合成的最后一步。关键物质茚并[2,1- a ] [3]苯并ze庚因是通过Bischler-Napieralski环化烷氧基取代的1-(2-溴苄基)-3-苯并ze庚因-2-酮制备的。检查了该合成中取代基的立体效应。
  • From protopines to berbines: synthesis of 1-methoxystylopine and its N-metho salts from coulteropine
    作者:Maria Valpuesta、Amelia Diaz、Gregorio Torres、Rafael Suau
    DOI:10.1016/s0040-4020(02)00467-2
    日期:2002.6
    The transformation of protopines into berbines under improved conditions has been used to synthesize 1-methoxystylopine. Coulteropine, the main alkaloid from Romneya coulteri, was used as the starting protopine to accomplish the stereocontrolled synthesis of both cis and transN-methyl-1-methoxystylopinium salts. The results of ab initio calculations (B3LYP/6-31G∗∗) which are consistent with experimental
    在改善的条件下将原松树素转化为小bin碱已被用于合成1-甲氧基stylopine。Coulteropine,从主要生物碱Romneya coulteri,被用作起始普罗托实现两者的立体控制合成顺式和反式ñ -甲基-1- methoxystylopinium盐。从头算的结果(B3LYP / 6-31G ∗∗)与实验数据一致,维持了C-1取代基对小bin素的构象平衡和N-甲基化率的影响。
  • Osada, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1927, p. 102,104
    作者:Osada
    DOI:——
    日期:——
  • Danckwortt, Archiv der Pharmazie, 1912, vol. 250, p. 637
    作者:Danckwortt
    DOI:——
    日期:——
  • Hopfgartner, Monatshefte fur Chemie, 1898, vol. 19, p. 197
    作者:Hopfgartner
    DOI:——
    日期:——
查看更多

同类化合物

5-formyl-2-cyclopentylmethyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo[3,4:6,7]cyclohepta[1,2-c]pyrrole hydrochloride dibenzo[i,k]-benzo[4,5]imidazo[1,2-f]phenanthridine 2-{4-[9-(5,8,9,14-tetrahydrodibenzo[d,g]azecin-7(6H)-yl)nonyl]piperazin-1-yl}ethanol (2R,3aR,12bS)-11-fluoro-2-[(methylamino)methyl]-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrole-1(2H)-carbaldehyde [(2R,3aR,12bS)-11-fluoro-1-(methoxyacetyl)-1,2,3,3a,8,12b-hexahydrodibenzo-[3,4:6,7]cyclohepta[1,2-b]pyrrol-2-yl]-N,N-dimethylmethanamine 2-[(2R,3aR,12bS)-2-[(dimethylamino)methyl]-11-fluoro-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrol-1(2H)-1-yl]ethanol [(2R,3aR,12bS)-11-fluoro-1-(2-methoxyethyl)-1,2,3,3a,8,12b-hexahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrol-2-yl]-N,N-dimethylmethanamine [(2R,3aR,12bS)-11-fluoro-1-methyl-1,2,3,3a,8,12b-hexahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrol-2-yl]-N,N-dimethylmethanamine methyl (2R,3aR,12bS)-2-(aminomethyl)-11-fluoro-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrole-1(2H)-carboxylate 6-allyl-3,4-dimethoxy-10-hydroxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 6,7,15-trimethyl-7-nitro-5,6,6a,7,8,13,14,14a-octahydro-5,13-cyclo-8,14-epiazano-benzo[5,6]cycloocta[1,2-c]isoquinoline 6-Benzyl-3,4-dimethoxy-10-hydroxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 3,4-Dimethoxy-11-hydroxy-6-methyl-5,6,7,8.13,14-hexahydrodibenz[c,g]azecine 6-benzyl-3,4-dimethoxy-11-hydroxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 2,3-dimethoxy-7-methyl-5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizinium iodide 5,6-Dimethoxy-11-methyl-11-aza-tricyclo[12.4.0.03,8]octadeca-1(14),3(8),4,6,15,17-hexaene (3S,3aR,12bS)-8-Dicyanomethylene-2,3-diphenyl-3,3a,8,12b-tetrahydro-2H-dibenzo[3,4;6,7]cyclohepta[1,2-c]pyrrole-1,1-dicarboxylic acid dimethyl ester (3S,3aR,12bS)-8-Dicyanomethylene-2-phenyl-3,3a,8,12b-tetrahydro-2H-dibenzo[3,4;6,7]cyclohepta[1,2-c]pyrrole-1,1,3-tricarboxylic acid trimethyl ester markiertes 2-Nitro-4,13-dimethyl-4,13-diazadibenzo<6.7,11,12>tetracyclo<7.3.1.03,8.05,10>tridecadien-(6,11) 3,4-dimethoxy-6-methyl-5,6,7,8,13,14-hexahydro-dibenzo[c,g]azecin-10-ol (2R,3aR,12bS)-11-fluoro-2-(hydroxymethyl)-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrole-1(2H)-carbaldehyde 1H-3a,8-Methanodibenzo(3,4:6,7)cyclohepta(1,2-c)pyrrole, 2,3,8,12b-tetrahydro-2-(cyclohexylmethyl)-8-methyl-, hydrochloride, (3a-alpha,8-alpha,12b-beta)- 1H-3a,8-Methanodibenzo(3,4:6,7)cyclohepta(1,2-c)pyrrole, 2,3,8,12b-tetrahydro-2-(cyclopentylmethyl)-1-methyl-, hydrochloride, (1-alpha,3a-alpha,8-alpha,12b-beta)- 3,12-dimethyl-3-azapentacyclo[10.6.1.01,5.06,11.013,18]nonadeca-6,8,10,13,15,17-hexaene;hydron;chloride 14-hydroxy-3,4-dimethoxy-5,6,7,8,14,15-hexahydrobenzo<1,3>dioxolo<4,5-k><3>benzazecine-6-carbonitrile 7-methyl-5,6,7,8,9,15-hexahydrobenzo[d][1,3]benzodioxolo[5,6-g]azecine 6-Acetyl-3,4-dimethoxy-5,8,14,15-tetrahydro-6H-benzo[c][1,3]dioxolo[4',5':4,5]benzo[1,2-g]azecin-7-one 6-benzyl-3,4-dimethoxy-10,11-methylenedioxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 4MP-Dhx 6-methyl-5,6,7,8,9,14-hexahydrodibenzo[c,f]azecin-11-ol 10-methoxy-6-methyl-5,6,7,8,13,14-hexahydrodibenzo[c,g]azecine 3,3a(2)-[1,3-Propanediylbis(oxy)]bis[5,8,9,13b-tetrahydro-7-methyl-6H-dibenzo[a,h]quinolizinium] 7-methyl-6,7,8,9-tetrahydrodibenz[d,g]azecin-14(5H)-one N-benzyl-N-nordihydroallocryptopine 2-Methyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo<3,4;6,7>cyclohepta<1,2-c>pyrrol-1-on dihydroallocryptopine 3-methoxy-7-methyl-6,7,8,9-tetrahydrodibenz[d,g]azecin-14(5H)-one (6aR,12bS)-(+)-6-((R)-α-methoxyphenylacetyl)-10,11-dimethoxy-5,6,6a,7,8,12b-hexahydrobenzophenanthridine (6aS,12bR)-(-)-6-((R)-α-methoxyphenylacetyl)-10,11-dimethoxy-5,6,6a,7,8,12b-hexahydrobenzophenanthridine 2-cyclopentylmethyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo[3,4:6,7]cyclohepta[1,2-c]pyrrole 5-formyl-2-cyclopentylmethyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo[3,4:6,7]cyclohepta[1,2-c]pyrrole (1S,2S,9R,11R,12S,13S,20R)-10,21-dimethyl-12-nitro-10,21-diazahexacyclo[11.7.1.02,11.03,8.09,20.014,19]henicosa-3,5,7,14,16,18-hexaene (1S,2S,9S,11R,12S,13S,20R)-10,21-dimethyl-12-nitro-10,21-diazahexacyclo[11.7.1.02,11.03,8.09,20.014,19]henicosa-3,5,7,14,16,18-hexaene 6-benzyl-10,11-dimethoxy-2-phenyl-6a,7,8,12b-tetrahydro-5H-benzo[a]phenanthridine 6-Propyl-5,6,6a,7,8,12b-hexahydro-benzo[a]phenanthridine-10,11-diol (2S)-7,8-dimethoxy-11-methyl-17,19-dioxa-11-azoniatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-ol (2R)-7,8-dimethoxy-11-methyl-17,19-dioxa-11-azoniatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-ol 7-Methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine (3R)-15-methyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-ol (3S)-15-methyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-ol